WCM Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-151,103
Closed -$6.14M 226
2023
Q1
$6.14M Buy
151,103
+456
+0.3% +$18.9K 0.02% 150
2022
Q4
$6.77M Sell
150,647
-2,204
-1% -$99.8K 0.02% 148
2022
Q3
$7.6M Buy
152,851
+10,567
+7% +$579K 0.03% 132
2022
Q2
$8.56M Buy
142,284
+36,008
+34% +$2.96M 0.03% 131
2022
Q1
$12.4M Buy
106,276
+9,964
+10% +$1.16M 0.03% 114
2021
Q4
$14.5M Sell
96,312
-7,415
-7% -$1M 0.03% 101
2021
Q3
$12.4M Buy
103,727
+1,101
+1% +$121K 0.03% 107
2021
Q2
$10M Buy
102,626
+32,475
+46% +$2.9M 0.03% 126
2021
Q1
$6.19M Sell
70,151
-1,957
-3% -$182K 0.02% 132
2020
Q4
$6.9M Buy
72,108
+198
+0.3% +$20.4K 0.02% 132
2020
Q3
$8.16M Sell
71,910
-12,665
-15% -$1.33M 0.03% 107
2020
Q2
$8.37M Sell
84,575
-31,441
-27% -$2.51M 0.03% 80
2020
Q1
$7.47M Buy
116,016
+25,732
+29% +$1.8M 0.04% 68
2019
Q4
$5.38M Buy
90,284
+66,055
+273% +$4.07M 0.03% 97
2019
Q3
$1.43M Buy
24,229
+5,819
+32% +$371K 0.01% 102
2019
Q2
$1.19M Buy
+18,410
New +$1.19M 0.01% 125

Other funds holding TNDM

WCM Investment Management's TNDM Position: Q2 2023 in Review

WCM Investment Management sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 151,103 shares — an estimated $6.14M sold.

WCM Investment Management first reported a position in TNDM in Q2 2019 and held it in 16 quarters. The position peaked at $14.5M in Q4 2021. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

  • WCM Investment Management reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
  • WCM Investment Management sold 151,103 Tandem Diabetes Care shares in Q2 2023, an estimated $6.14M.
  • WCM Investment Management first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 16 quarters.
  • WCM Investment Management's Tandem Diabetes Care position peaked at $14.5M in Q4 2021.
  • 247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on WCM Investment Management's 13F filing for Q2 2023, filed 14 Jul 2023.